[{"id":"ffeeab14-f63d-4771-bcc1-d02b2ffc0da9","acronym":"","url":"https://clinicaltrials.gov/study/NCT01440920","created_at":"2021-01-18T05:58:16.428Z","updated_at":"2024-07-02T16:36:33.686Z","phase":"Phase 1","brief_title":"A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients","source_id_and_acronym":"NCT01440920","lead_sponsor":"Otsuka Pharmaceutical Co., Ltd.","biomarkers":" RARA • HLA-DRB1","pipe":" | ","alterations":" HLA-DRB1*01:01","tags":["RARA • HLA-DRB1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e HLA-DRB1*01:01"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e OCV-501"],"overall_status":"Completed","enrollment":" Enrollment 9","initiation":"Initiation: 09/01/2011","start_date":" 09/01/2011","primary_txt":" Primary completion: 03/01/2013","primary_completion_date":" 03/01/2013","study_txt":" Completion: 07/01/2013","study_completion_date":" 07/01/2013","last_update_posted":"2021-03-08"}]